Patents by Inventor Andreas Fuchs

Andreas Fuchs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Certain di-aryl-1,2,3,6-tetrahydro-pyridyl-n-lower-alkylene-pyridines having neuroleptic properties
    Patent number: 4760082
    Abstract: New pyridine derivatives of the formula I ##STR1## wherein R.sup.1 and R.sup.2 are each phenyl or 2- or 3-thienyl radicals which are unsubstituted or monosubstituted or di-substituted by alkyl, alkoxy, F, Cl, Br, OH and/or CF.sub.3 and n is 1, 2 or 3, and the alkyl and alkoxy groups each have 1-4 C atoms, and salts thereof, have suppressant actions on the central nervous system, in particular neuroleptic actions.
    Type: Grant
    Filed: February 13, 1987
    Date of Patent: July 26, 1988
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Henning Bottcher, Andreas Fuchs, Christoph Seyfried
  • Certain 1,2,3,6-tetrahydro-pyridyl-N-lower-alkanoyl-pyridines as intermediates
    Patent number: 4665187
    Abstract: New pyridine derivatives of the formula I ##STR1## wherein R.sup.1 and R.sup.2 are each phenyl or 2- or 3-thienyl radicals which are unsubstituted or monosubstituted or disubstituted by alkyl, alkoxy, F, Cl, Br, OH and/or CF.sub.3 and n is 1, 2 or 3, and the alkyl and alkoxy groups each have 1-4 C atoms, and salts thereof, have suppressant actions on the central nervous system, in particular neuroleptic actions.
    Type: Grant
    Filed: October 18, 1985
    Date of Patent: May 12, 1987
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Henning Bottcher, Andreas Fuchs, Christoph Seyfried
  • 1-(p-2-Isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol for decreasing the intra-ocular pressure and an ophthalmic preparation thereof
    Patent number: 4522829
    Abstract: 1-(p-2-iso-propoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol and its biocompatible salts are very useful in decreasing the intra-ocular pressure, e.g., to treat glaucoma.
    Type: Grant
    Filed: June 30, 1982
    Date of Patent: June 11, 1985
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Jurgen Harting, Andreas Fuchs